Evogene Reports Second Quarter 2019 Financial Results; Investors Slides
false
אבוגן בע"מ
2
380
EVOGENE LTD
Corporation no:
512838723
11441
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
31/07/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-079339
Time of broadcast:
10:58
10:52:32
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Evogene Reports Second Quarter 2019 Financial Results; Investors Slides
Evogene_Q2_results_and_Slides_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
25/06/2019
Address:
Gad Feinstein St
13, P.O.B 2100
,
Rehovot
76121
,
Tel:
08-9311900
,
Fax:
08-9466724
E-mail address:
ofer.haviv@evogene.com
Company site:
www.evogene.com
Previous names of reporting entity:
Name of the Signatory:
Bartov Pinto Amitai
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
Gad Feinstein
13
,
Rehovot
7612002
Telephone:
08-9311962
Facsimile:
08-9466724
E-mail:
amitai.bartov@evogene.com
1